Advertisement

Topics

Search Results for "Takeda"

02:43 EST 9th February 2016 | BioPortfolio

Matching Channels

Pertussis Vaccine acellular Takeda

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

More than 96 Percent of Claimants Opt-In to ACTOS Resolution Program;Takeda Expects Resolution to Become Effective Once Submission Review Completed;Takeda Stands Behind ACTOS

Deerfield, Ill., Sept. 11, 2015 – Takeda Pharmaceutical Company Limited (TSE: 4502) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (collectively “Takeda”), toda...

More than 96 Percent of Claimants Opt-In to ACTOS Resolution Program;Takeda Expects Resolution to Become Effective Once Submission Review Completed; Takeda Stands Behind ACTOS

Deerfield, Ill., Sept. 11, 2015 – Takeda Pharmaceutical Company Limited (TSE: 4502) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (collectively “Takeda”), toda...

Takeda berichtet Verkauf seiner Atemwegstherapeutika-Sparte an AstraZeneca

Spartenverkauf ermöglicht Takeda Konzentration auf sein Kerngeschäft: insbesondere Therapeutika in den Bereichen Gastroenterologie und Onkologie Takeda Pharmaceutical Company Limited (TOKYO:4502) .....

Takeda inks deal with Nanotherapeutics for access to Vero cell technology

Japan’s Takeda Pharmaceutical has signed an agreement with USA-based Nanotherapeutics providing Takeda…

Takeda, Gencia to develop mitochondrial candidates

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) and Gencia LLC (Charlottesville, Va.) partnered to develop mitochondrial agonists of the glucocorticoid receptor (MAGR). Gencia is eligible for $500 million...

Takeda make a strategic acquisition

In this episode of PharmaTelevision News Review, Fintan Walton talks to Nigel Borshell, Director at PharmaVentures. Nycomed’s geographic presence in Europe and Emerging markets a strong justificati...

Takeda Announces Details of New Business Venture with Teva in Japan

Osaka, Japan, December 28, 2015 – Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") today announced the details of the business venture which was disclosed November 30, 2015 in the pr...

Mersana, Takeda Expand Partnership to Advance Development of Antibody Drug Conjugates

​Mersana Therapeutics and Takeda announced that they have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the United States and Ca...

Matching PubMed Articles

Takeda moves into stem cells.

Quantitative determination of the antidepressant vortioxetine and its major human metabolite in plasma.

Vortioxetine is a novel antidepressant that has been developed in a joint partnership between H. Lundbeck A/S and the Takeda Pharmaceutical Company, Ltd.

Use of different criteria to assess inadequate prenatal care: a population-based study in Southern Brazil.

This study measured the prevalence of inadequate prenatal care and identified associated factors using different criteria in postpartum women in Rio Grande, Rio Grande do Sul State, Brazil, in 2010. A...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement